Skip to main content
ACAD
NASDAQ Life Sciences

Acadia Lands Japan Distribution Deal for DAYBUE With $30M Upfront

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.789
Mkt Cap
$3.241B
52W Low
$15.855
52W High
$30.96
52W Position info
19% above low
Off High info
39% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ACAD sits 19% above its 52-week low of $15.855.

Summary

Acadia signed Kyorin Pharmaceutical as its Japanese distributor for DAYBUE Stix (trofinetide) in Rett syndrome. Kyorin pays $30 million upfront, plus up to $45 million in milestones tied to an NHI price listing and net sales targets, with additional undisclosed payments. The deal monetizes a market Acadia has not yet commercialized directly and adds non-dilutive cash to a balance sheet that already held $976.4 million at the end of Q3. It follows the August European Commission approval of DAYBUE, extending the franchise's ex-U.S. reach. The upfront is modest next to Acadia's roughly $3.2 billion market value, so the milestone structure and any Japanese launch timing matter more than the headline cash.

At the time of this announcement, ACAD was trading at $18.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $15.86 to $30.96. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ACAD - Latest Insights

ACAD
Nov 04, 2026, 6:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.95
Real-time Price: $18.79 info
Change: -$3.16 (-14%) info
Market Cap: $3.241B info
ACAD
Nov 04, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $21.46
Real-time Price: $18.79 info
Change: -$2.67 (-12%) info
Market Cap: $3.241B info
ACAD
Oct 05, 2026, 2:23 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $20.07
Real-time Price: $18.79 info
Change: -$1.28 (-6%) info
Market Cap: $3.241B info
ACAD
Sep 28, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $20.53
Real-time Price: $18.79 info
Change: -$1.74 (-8%) info
Market Cap: $3.241B info
ACAD
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.65
Real-time Price: $18.79 info
Change: -$1.86 (-9%) info
Market Cap: $3.241B info